Is Citius Pharma Ctxr Stock In Consolidation Phase Price At 0.85 Up 1.30 20260402 FR Q1 2026 Earnings Massive EPS Beat Drives Positive Market Reaction Frontline Plc FRO Q4 2025 Earnings EPS Misses Consensus Stock Declines on Profit Disappointment JOE Q1 2026 Earnings Modest EPS Performance Amid Limited Financial Disclosures Design Therapeutics Inc DSGN Q1 2026 Earnings Narrower Loss Surpasses Expectations Amid Quiet Quarter HSY Q1 2026 Earnings EPS Surges Past Estimates Shares Rise on Confectionery Strength DTI Q1 2026 Earnings EPS Misses Expectations as Stock Declines WALD Q4 2024 Earnings EPS Misses Estimates Significantly as Stock Rises Nexalin Technology Q1 2026 Earnings EPS Misses Estimates Amidst Narrowing Losses WRB Q1 2026 Earnings Strong Underwriting and Investment Performance Drive 124 EPS Beat ATYR Q1 2026 Earnings Narrower Loss Per Share Beats Expectations Stock Dips on Pipeline Update GSK Q1 2026 Earnings EPS Beats Estimates Amid Revenue Data Gap Aeva Technologies Q1 2026 Earnings Lidar Technology Firm Beats EPS Estimates as Stock Surges JKS Q4 2025 Earnings Significant EPS Miss Despite Modest Share Gain